Skip to main content
Clinical Trials/NCT04371328
NCT04371328
Completed
Not Applicable

Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection (Unit "COVID Possible")

University Hospital, Toulouse1 site in 1 country1,860 target enrollmentMarch 13, 2020
ConditionsEmergencies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emergencies
Sponsor
University Hospital, Toulouse
Enrollment
1860
Locations
1
Primary Endpoint
Describe the characteristics of patients admitted to reCOP units according to their virological status vis-à-vis COVID-19
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This research aims to improve knowledge of the epidemiology of patients consulting in the COvid Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. It will be necessary to identify the diagnosis of the dyspneic patient and to define his virological status COVID before referring him to the appropriate units.

The investigatory propose an original strategy of dedicating entire care sectors to the care of patients admitted for dyspnea in our ER. These units will be named RECOP units.

This study would improve epidemiological knowledge of COVID-19 and ability to receive these patients within the SU.

Registry
clinicaltrials.gov
Start Date
March 13, 2020
End Date
June 30, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients over the age of 15 admitted to the RECOP unit for dyspnea

Exclusion Criteria

  • Patient admitted to shock for respiratory distress requiring immediate respiratory support.
  • Patient under justice safeguard

Outcomes

Primary Outcomes

Describe the characteristics of patients admitted to reCOP units according to their virological status vis-à-vis COVID-19

Time Frame: 30 days

The virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking

Secondary Outcomes

  • Develop a predictive model of the risk of being COVID for patients admitted to the emergency room for dyspnea(0 days)

Study Sites (1)

Loading locations...

Similar Trials